Established in 1984, Dr. Reddy’s Laboratories (New York Stock Exchange listed: RDY) is a fast emerging global pharmaceutical company, whose purpose is providing affordable and innovative medicines for healthier lives. Dr. Reddy’s is vertically integrated with a presence across the pharmaceutical value chain through its core businesses of Global Generics, Pharmaceutical Services & Active Ingredients (PSAI), and Proprietary Products, which includes New Chemical Entities, Biosimilars and Differentiated formulations. Dr. Reddy’s conducts NCE drug discovery research in the areas of metabolic disorders, cardiovascular indications, anti-infective and inflammation. The company’s products are marketed globally, with a focus primarily on India, US, Europe and Russia, aside from these important geographies company is also keen on increasing market share in other important geographies such as Vietnam.